403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Grupo Toky, Oncoclínicas, Rumo Q3 2025 Results
(MENAFN- The Rio Times) Three very different Brazilian stories are emerging from the latest earnings season. Grupo Toky, a furniture and home-décor retailer, is finally putting a fragile turnaround on the scoreboard.
Oncoclínicas, a fast-growing cancer-care network, has slammed on the brakes with a huge clean-up of its balance sheet. And rail operator Rumo, a key corridor for the country's agribusiness exports, is delivering strong volumes but worrying investors with weaker pricing and higher debt costs.
Together, they show how Brazil's listed companies are trying to adapt to slower growth, higher rates and tighter funding.
Grupo Toky – Retailer Fighting Back After A Costly Restructuring
Grupo Toky, which combines online player Mobly and chain Tok&Stok, sells furniture and home décor to Brazil's middle class.
In the third quarter, it almost stopped losing money: net loss shrank to about R$ 0.3 million (around $0.1 million), from roughly R$ 22 million (about $4 million) a year earlier.
Net operating revenue more than doubled to around R$ 340 million (about $63 million) from R$ 151 million (about $28 million), and EBITDA swung from slightly negative to about R$ 71 million (around $13 million).
Gross merchandise volume reached close to R$ 494 million (about $92 million), showing the new group is gaining scale.
The story behind the numbers is a company emerging from an expensive restructuring and governance fight. Toky is converting a R$ 25 million (about $5 million) creditor claim from Domus Aurea into equity at R$ 1.00 per share, reducing leverage and interest costs and trying to stop financial issues from eating its commercial recovery.
The next chapters will show whether this lighter balance sheet and tighter cost control are enough to deliver consistent profit in a still-weak consumer market.
Oncoclínicas – Cancer-Care Group Uses A“Kitchen-Sink” Quarter
Oncoclínicas runs oncology clinics and treatment centers across Brazil. Its third quarter was brutal on paper: a net loss of roughly R$ 1.88 billion (about $348 million), against a small profit a year before.
Even on an adjusted basis, it posted a loss of about R$ 98 million (around $18 million). The company booked very large provisions, together over R$ 900 million (about $172 million), and wrote down assets by almost R$ 650 million (around $120 million).
Revenue fell about 14% to roughly R$ 1.41 billion (about $261 million), and adjusted EBITDA dropped to around R$ 241 million (about $45 million).
Behind the cautious language about“recalibrating the route” sits a clear message: the previous expansion and acquisition strategy was too aggressive for the balance sheet.
A new capital increase of roughly R$ 1 billion (about $185 million) – the third in two years – is meant to reduce leverage and buy time.
Investors will now watch whether management can shift from chasing scale to protecting cash and margins in a sector where demand is strong but funding is no longer cheap.
Rumo – Rail Champion With Volume Up, Pricing And Debt Under Pressure
Rumo operates freight railways moving grain, sugar, fuel and other goods from Brazil's interior to ports. In the third quarter, transported volumes rose 8.2%, and adjusted EBITDA grew 4.5% to around R$ 2.31 billion (about $428 million).
Net revenue, however, increased only 1.8% to about R$ 3.82 billion (around $707 million), and net profit slipped 7.6% to roughly R$ 733 million (about $136 million). Tariffs fell in a more competitive market, so more cargo did not translate into much more revenue.
Costs for services rose nearly 5% to around R$ 1.98 billion (about $367 million), while higher interest rates and a 46% jump in net debt pushed leverage from 1.4 to 1.9 times EBITDA. A one-off indemnity of R$ 55 million (about $10 million) helped soften the hit to profit.
The story behind the headline is a classic trade-off: Rumo remains a strategic, long-term play on Brazil's export logistics, but the market is signaling that it wants proof that rising volumes will not be swallowed by lower freight prices and more expensive debt.
Oncoclínicas, a fast-growing cancer-care network, has slammed on the brakes with a huge clean-up of its balance sheet. And rail operator Rumo, a key corridor for the country's agribusiness exports, is delivering strong volumes but worrying investors with weaker pricing and higher debt costs.
Together, they show how Brazil's listed companies are trying to adapt to slower growth, higher rates and tighter funding.
Grupo Toky – Retailer Fighting Back After A Costly Restructuring
Grupo Toky, which combines online player Mobly and chain Tok&Stok, sells furniture and home décor to Brazil's middle class.
In the third quarter, it almost stopped losing money: net loss shrank to about R$ 0.3 million (around $0.1 million), from roughly R$ 22 million (about $4 million) a year earlier.
Net operating revenue more than doubled to around R$ 340 million (about $63 million) from R$ 151 million (about $28 million), and EBITDA swung from slightly negative to about R$ 71 million (around $13 million).
Gross merchandise volume reached close to R$ 494 million (about $92 million), showing the new group is gaining scale.
The story behind the numbers is a company emerging from an expensive restructuring and governance fight. Toky is converting a R$ 25 million (about $5 million) creditor claim from Domus Aurea into equity at R$ 1.00 per share, reducing leverage and interest costs and trying to stop financial issues from eating its commercial recovery.
The next chapters will show whether this lighter balance sheet and tighter cost control are enough to deliver consistent profit in a still-weak consumer market.
Oncoclínicas – Cancer-Care Group Uses A“Kitchen-Sink” Quarter
Oncoclínicas runs oncology clinics and treatment centers across Brazil. Its third quarter was brutal on paper: a net loss of roughly R$ 1.88 billion (about $348 million), against a small profit a year before.
Even on an adjusted basis, it posted a loss of about R$ 98 million (around $18 million). The company booked very large provisions, together over R$ 900 million (about $172 million), and wrote down assets by almost R$ 650 million (around $120 million).
Revenue fell about 14% to roughly R$ 1.41 billion (about $261 million), and adjusted EBITDA dropped to around R$ 241 million (about $45 million).
Behind the cautious language about“recalibrating the route” sits a clear message: the previous expansion and acquisition strategy was too aggressive for the balance sheet.
A new capital increase of roughly R$ 1 billion (about $185 million) – the third in two years – is meant to reduce leverage and buy time.
Investors will now watch whether management can shift from chasing scale to protecting cash and margins in a sector where demand is strong but funding is no longer cheap.
Rumo – Rail Champion With Volume Up, Pricing And Debt Under Pressure
Rumo operates freight railways moving grain, sugar, fuel and other goods from Brazil's interior to ports. In the third quarter, transported volumes rose 8.2%, and adjusted EBITDA grew 4.5% to around R$ 2.31 billion (about $428 million).
Net revenue, however, increased only 1.8% to about R$ 3.82 billion (around $707 million), and net profit slipped 7.6% to roughly R$ 733 million (about $136 million). Tariffs fell in a more competitive market, so more cargo did not translate into much more revenue.
Costs for services rose nearly 5% to around R$ 1.98 billion (about $367 million), while higher interest rates and a 46% jump in net debt pushed leverage from 1.4 to 1.9 times EBITDA. A one-off indemnity of R$ 55 million (about $10 million) helped soften the hit to profit.
The story behind the headline is a classic trade-off: Rumo remains a strategic, long-term play on Brazil's export logistics, but the market is signaling that it wants proof that rising volumes will not be swallowed by lower freight prices and more expensive debt.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment